8-K: Eton Pharma to Present at Piper Sandler Healthcare Conference

Eton Pharmaceuticals, Inc. announced its management will present at the Piper Sandler Annual Healthcare Conference on December 4, 2025.

Summary

• Eton Pharmaceuticals, Inc. (ETON) management team will attend the Piper Sandler Annual Healthcare Conference in New York, NY.
• A corporate slide presentation, attached as Exhibit 99.1, will be presented at the conference and in meetings with investors and other parties.
• The information contained in this report and Exhibit 99.1 is for Regulation FD disclosure and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934 or incorporated by reference in other filings, unless expressly set forth by specific reference.

Sentiment

Score: 5

Explanation: The filing is a routine administrative announcement regarding participation in an investor conference, providing no specific financial or operational updates to influence sentiment positively or negatively.

Future Outlook

NA

Industry Context

Participation in a major healthcare conference is a standard practice for pharmaceutical companies to engage with the investment community, present corporate updates, and discuss strategic initiatives.

Stakeholder Impact

• Shareholders and investors: Provides an opportunity to access the company's corporate presentation and hear from management, potentially enhancing transparency and engagement.

Next Steps

• Management team will attend and present the corporate slide presentation at the Piper Sandler Annual Healthcare Conference.
• The corporate slide presentation (Exhibit 99.1) will be made available to investors and other parties.

Key Dates

Keywords

Eton Pharmaceuticals, ETON, Piper Sandler, Healthcare Conference, Investor Relations, Pharmaceuticals, 8-K Filing